• News & Media
  • Careers
  • Contact Us
  • ""
  • Home
  • About Us
  • BUSINESSES
  • Foundation
  • Investor
News & Media Careers Contact Us
  • Home
  • About Us
    • Who We Are
    • Our Values
    • Our History
    • Board of Directors
    • Management Team
  • Business
    • Piramal Enterprises
    • Piramal Glass
    • Piramal Realty
  • Foundation
  • investor
    • Overview
    • Financial Reports
    • Corporate Governance
    • Shareholder Information
    • Investor Contacts
  • Privacy Policy
  • Disclaimer
  • © 2020 Piramal Enterprises Ltd.
  • Financial
    Reports
  • Corporate
    Governance
  • Shareholder
    Information
  • Investor
    Contacts
  • Financial
    Services Day

Shareholder Information
& Services

  1. Investors
  2. Shareholder Information
  3. Announcements

Shareholder Information

  • Shareholding
    Pattern
  • Notice
  • Share
    Capital
  • Dividend
  • Unclaimed
    Dividend
  • Credit
    Rating
  • PPMLD
    Valuation
  • Forms
  • Announcements
  • Statement of
    Employees
  • ESOP
    Disclosure
  • Scheme of
    Amalgamation
  • Rights
    Issue
  • PEL – Appointment of Independent Director – 19th November, 2020

  • PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and half year ended 30th September, 2020

  • PEL – Auditors’ Report with UDIN for the quarter and half year ended 30th September, 2020

  • PEL – Acquisition of stake in Convergence Chemicals Private Limited by Piramal Pharma Limited – 28th October, 2020

  • PEL – Resignation of Independent Directors – 28th October, 2020

  • PEL – Outcome of the Board Meeting – 28th October, 2020

  • PEL – Notice of Board Meeting published in Newspapers

  • PEL – Board Meeting Notice- 28th October, 2020

  • PEL – Appointment of Independent Directors – 15th October, 2020

  • PEL – Completion of transfer of Pharma Business and 20% Strategic Growth Investment by Carlyle – 6th October, 2020

  • PEL – Analyst Meet – 9th & 10th September, 2020

  • PEL – Analyst Meet – 31st August, 2020

  • PEL – Analyst Meet – 24th August, 2020

  • PEL – Analyst Meet – 17th August, 2020

  • PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter ended 30th June, 2020

  • PEL – Scrutinizer’s Report for Annual General Meeting for FY 2019-2020

  • PEL – Proceedings of the 73rd Annual General Meeting – 30th July, 2020

  • PEL – Auditors’ Report with UDIN for the quarter ended 30th June, 2020

  • PEL – Outcome of the Board Meeting – 30th July, 2020

  • PEL – Analyst Meet – 28th July, 2020

  • PEL – Notice of Board Meeting published in Newspapers.

  • PEL – Board Meeting Notice – 30th July, 2020

  • PEL – Newspaper Advertisement for Notice of 73rd Annual General Meeting.

  • PEL – Newspaper Advertisement – Information regarding 73rd Annual General Meeting (‘AGM’) and Book Closure.

  • PEL – Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment

  • PEL – Update on acquisition of G&W Laboratories Inc.

  • PEL – Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

  • PEL –Auditors’ Report with UDIN for the quarter and financial year ended 31st March, 2020

  • Outcome of the Board Meeting – Audited Financial Results – 11th May, 2020

  • Outcome of the Board Meeting – 11th May, 2020

  • PEL – Board Meeting Notice – 11th May, 2020

  • PEL – Analyst Meet – 8th May, 2020

  • CARE Credit Rating – 22nd April, 2020

  • PEL – Intimation of Credit Rating

  • PEL – Intimation to consider Interim Dividend

  • PEL – Update on Divestment of stake in DRG Business – 2nd March, 2020

  • PEL – Outcome of the Board Meeting – 4th February, 2020

  • PEL – Outcome of Committee Meeting – 29th January, 2020

  • PEL- Board Meeting Notice- 4th February, 2020

  • PEL – Divestment of stake in DRG Business – 17th January, 2020

  • Proceedings of the Extraordinary General Meeting – 25th November, 2019

  • Scrutinizer’s report for Extraordinary General Meeting – 25th November, 2019

  • PEL – Limited Review Report for the quarter ended 30th September, 2019

  • PEL – Board Meeting Notice – 21st October, 2019

  • PEL Files Complaint with SEBI regarding misleading rumors about the Company

  • PEL- Outcome of Committee Meeting – 13th September, 2019

  • PEL-Analyst Meet- 11rd September, 2019 & 12th September,2019

  • PEL-Analyst Meet- 11th September, 2019 & 12th September,2019

  • Outcome of Committee Meeting – 28th August, 2019

  • PEL-Analyst Meet- 3rd September, 2019 & 4th September,2019

  • PEL-Analyst Meet-19th August, 2019

  • Proceeding of the 72nd Annual General Meeting – 30th July,2019

  • PEL-Analyst Meet-29th August, 2019 & 30th August,2019

  • Scrutinizer’s Report for Annual General Meeting for FY 2018-2019

  • PEL – Board Meeting Notice -30th July, 2019

  • PEL – Intimation of Conference Call – 30th June, 2019

  • PEL – Outcome of Committee Meeting – 12th July, 2019

  • PEL – Outcome of Committee Meeting – 10th July, 2019

  • PEL – Outcome of Committee Meeting – 12th June, 2019

  • PEL – Outcome of Committee Meeting – 11th June, 2019

  • PEL – Analyst Meet – 7th June, 2019

  • PEL – Analyst Meet – 12th June, 2019

  • PEL – Analyst Meet – 5th June, 2019

  • PEL – Analyst Meet – 3rd June, 2019

  • PEL – Allotment of Shares out of CCD Reservation portion – 30th May, 2019

  • PEL – Analyst Meet – 29th May, 2019

  • PEL– Allotment of shares out of CCD Reservation portion – 21st May, 2019

  • PEL- Extract of Audited Financial Results for the quarter / year ended March 31, 2019 published in newspapers – English – Business Standard and Marathi-Mumbai Lakshadeep

  • PEL- Notice of Board Meeting published in newspapers – English –The Free Press Journal and Marathi-Navshakti

  • PEL – Updates

  • PEL – Analyst Meet – 13th – 16th May, 2019

  • PEL – Analyst Meet – 8th – 10th May, 2019

  • PEL – Outcome of the Board Meeting – 26th April, 2019

  • PEL – Analyst Meet – 22nd April, 2019

  • PEL Allotment of Shares pursuant to Conversion of CCD’s – 22nd April, 2019

  • PEL – Board Meeting Notice – 26th April, 2019

  • PEL – Allotment of shares out of CCD Reservation portion – 5th April, 2019

  • PEL – Allotment of shares Pursuant to CCD Conversion – 11th April, 2019

  • Record date for conversion of CCDs

  • PEL – Intimation of Record Date for CCD

  • PEL – Outcome of the Meeting of the Committee of Directors (Rights Issue) – 19th March, 2019

  • PEL – Outcome of the Committee Meeting – 14th March, 2019

  • PEL – Analyst Meet – 18th – 19th March, 2019

  • PEL – Press Release – Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S. – 12th March, 2019

  • PEL – Press Release – Piramal Critical Care announces the U.S. launch of MITIGO – 11th March, 2019

  • PEL – Press Release – Supreme Court Exempts Saridon from the List of Banned FDCs – 21st February, 2019

  • PEL – Analyst Meet – 4th March, 2019

  • PEL – Analyst Presentation

  • PEL – Analyst Meet – 18th February, 2019

  • PEL – Analyst Meet – 15th February, 2019

  • PEL – Analyst Meet – 14th February, 2019

  • Outcome of Committee Meeting – 12th February, 2019

  • PEL – Analyst Meet – 11th, 12th & 13th February, 2019

  • Outcome of Committee Meeting – 4th February, 2019

  • PEL – Transcript of Analyst Conference call – 28th January, 2019

  • PEL – Intimation of Conference call – 28th January, 2019

  • PEL – Board Meeting Notice – 28th January, 2019

  • Outcome of Committee Meeting – 16th January, 2019

  • PEL – Outcome of the Committee Meeting -2nd January, 2019

  • Outcome of Committee Meeting – 27th December, 2018

  • Outcome of Committee Meeting – 21st December, 2018

  • Outcome of Committee Meeting – 24th December, 2018

  • PEL – Intimation of Credit Rating

  • Outcome of Committee Meeting – 18th December, 2018

  • Outcome of Committee Meeting – 29th November, 2018

  • Outcome of Committee Meeting – 28th November, 2018

  • PEL – Analyst Meet – 28th November, 2018

  • Outcome of Committee Meeting – 22nd November, 2018

  • PEL – Analyst Meet – 22nd November, 2018

  • Outcome of Committee Meeting – 21st November, 2018

  • Outcome of Committee Meeting – 16th November, 2018

  • Outcome of Committee Meeting – 15th November, 2018

  • PEL – Analyst Meet – 15th November, 2018

  • PEL – Outcome of Committee Meeting – 13th November, 2018

  • PEL – Analyst Meet – 13th November, 2018

  • PEL – Outcome of the Board Meeting – 25th October, 2018

  • PEL – Transcript of Analyst Conference Call – 25th October, 2018

  • PEL – Outcome of Committee Meeting

  • PEL – Appointment of Director – 25th October, 2018

  • PEL – Intimation of Conference Call – 25th October, 2018

  • PEL – Outcome of the Committee Meeting – 5th October, 2018

  • PEL – Outcome of the Committee Meeting – 25th September, 2018

  • PEL Analysts / Institutional Investors Meeting Update – 24th September, 2018

  • PEL – Intimation of Credit Rating

  • PEL – Allotment of shares out of CCD Reservation portion – 17th September, 2018

  • PEL – Analyst Presentation – 30th August, 2018

  • PEL – Outcome of the Committee Meeting – 7th September, 2018

  • PEL – Analyst Meeting – 3rd September, 2018

  • PEL – Outcome of the Committee Meeting – 31st August, 2018

  • PEL – Analyst Meeting – 30th August, 2018

  • Transfer of shares in Demat Form

  • PEL – Transcript of Analyst Conference Call – 30th July, 2018

  • PEL – Analysts Meeting – 9th August, 2018

  • Scrutinizer’s Report for Annual General Meeting for FY 2017-18

  • Proceedings of the 71st Annual General Meeting – 30th July, 2018

  • PEL – Outcome of the Board Meeting – 30th July, 2018

  • PEL – Intimation of Conference Call – 30th July, 2018

  • PEL – Board Meeting Notice – 30th July, 2018

  • PEL – Allotment of shares out of CCD reservation portion

  • PEL – Newspaper’s AGM Notice

  • PEL – Divestment of stake in Piramal Imaging SA (PISA) – 26th June, 2018

  • PEL – Intimation of Analyst Meet- 7th June, 2018

  • PEL – Intimation of Analyst Meet – 5th June, 2018

  • PEL – Outcome of the Board Meeting – 28th May, 2018

  • PEL – Board Meeting Notice – 28th May, 2018

  • PEL – Outcome of the Committee Meeting – 15th May, 2018

  • PEL – Outcome of the Committee Meeting – 7th May, 2018

  • PEL – Shareholding Pattern (Post Allotment) – 8th March, 2018

  • PEL – Intimation of the Analyst Meet – 23rd March, 2018

  • PEL – Outcome of the Administrative Committee Meeting – 21st March, 2018

  • PEL – Outcome of the Meeting of the Committee of Directors (Rights Issue) – 8th March, 2018

  • PEL – Analyst Meet – 5th March, 2018

  • PEL – Outcome of the Committee Meeting – 12th February, 2018

  • PEL – Analyst Meet – 21st February, 2018

  • PEL – Analyst Meet – 8th February, 2018

  • PEL – Outcome of the Committee Meeting – 31st January, 2018

  • PEL – Outcome of the Board Meeting – 30th January, 2018

  • PEL – Board Meeting Notice – 30th January, 2018

  • Clarification in relation to Stock exchange intimation dated January 19, 2018

  • PEL – Outcome of Committee Meeting – 19th January, 2017

  • Timeline for conversion of CCDs into Equity Shares

  • PEL – Board Meeting Notice – 6th November, 2017

  • Piramal Enterprises QIP PD

  • Piramal Enterprises QIP PPD

  • PEL – Joint Venture with Bain Capital – 19th July, 2017

  • Proceedings of the 70th Annual General Meeting – 1st August, 2017

  • PEL – Chief Financial Officer – 28th June, 2017

  • PEL – Board Meeting Notice – 12th May, 2017

  • PEL – Outcome of the Board Meeting – 12th May, 2017

  • Press Release – Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC – 20th March, 2017

  • Change in Registered Office & Mumbai operation of the Registrar & Share Transfer Agent of the Company – 28th February, 2017

  • PEL – Investor/ Analyst Conference – 27th February, 2017 to 6th March, 2017

  • PEL – Analysts Meeting – 22nd February, 2017

  • PEL – Analyst Meeting – 14th February, 2017

  • PEL – Outcome of Board Meeting – 13th February, 2017

  • PEL – Transcript of Analyst Conference Call – 31st January, 2017

  • PEL – Board Meeting Notice – 13th February, 2017

  • PEL – Analyst Presentation – 31st January, 2017

  • PEL – Analyst Conference Call – 31st January, 2017

  • Press Release – Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC. – 30th January, 2017

  • PEL Outcome of Board Meeting – 5th January 2017

  • News Clarification – 28th December, 2016

  • PEL – Transcript of Analyst Conference Call – 22nd November, 2016

  • Press Release – Piramal Enterprises Limited announces its plan to enter housing finance – 5th January, 2017

  • PEL – Analyst Conference Call – 21st November, 2016

  • PEL – Analysts Meeting – 7th November, 2016 to 11th November, 2016

  • PEL – Board Meeting Notice – 27th October, 2016

  • Press Release – Agreement to acquire Janssen’s injectable anesthesia and pain management products by wholly-owned subsidiary. – 10th October, 2016

  • PEL – Stock Exchange Intimation for the Committee on 10th October, 2016

  • PEL – Outcome of Committee Meeting on 30th September, 2016

  • PEL – Stock Exchange Intimation for the Committee meeting on 30th September, 2016

  • PEL – Stock Exchange Intimation – 20th September, 2016 – Sell Down

  • PEL – Analysts Meet – 9th September, 2016

  • PEL – Analysts Meet – 30th August, 2016

  • News Clarification – 28th August, 2016

  • Stock Exchange Intimation for the Committee Meeting on 25th August, 2016

  • Stock Exchange intimation for the Committee Meeting on 11th August, 2016

  • Proceedings of the 69th Annual General Meeting – 1st August, 2016

  • PEL – Outcome of Annual General Meeting – 1st August, 2016

  • PEL – Board Meeting Notice – 1st August, 2016

  • PEL – Advertisement of Annual General Meeting – 1st August, 2016 – English

  • PEL – Advertisement of Annual General Meeting – 1st August, 2016 – Marathi

  • PEL – Analysts Meet – 27th June, 2016

  • PEL – Analysts Meet – 7th June, 2016

  • PEL – Board Meeting Notice – 16th May, 2016

  • Press Release – Agreement to acquire brands from Pfizer Limited – 13th May, 2016

  • PEL – Analysts Meet – 12th April, 2016

  • PEL – Analysts Meet – 29th March, 2016

  • Other Corporate Updates – 23rd March, 2016

  • PEL – Outcome of Committee Meeting held on 18th March, 2016

  • PEL – Outcome of Board Meeting held on 9th March, 2016

  • PEL – Analyst Meets 03rd March, 2016

  • PEL – Press Release Adaptive Acqn by DRG

  • PEL – Analyst Meets 15th February, 2016

  • PEL – KMP’s for determining materiality – 8th February, 2016

  • PEL – Board meeting notice – 1st February, 2016

Investor Presentation

  • PEL- Investor Presentation- Dec 2020

Download

Quick Links

  • Annual Report – FY 2019-20
  • Investor Presentation- Dec 2020
  • Investor Calls
  • Transfer of shares in Demat Form
  • Investor Contacts
  • Press Releases
  • In The News
Piramal Group
  • Piramal Enterprises Ltd.
  • Piramal Glass
  • Piramal Realty
  • Piramal Foundation
Piramal Enterprises Ltd.
  • Piramal Pharma
  • – Pharma Solutions
  • – Critical Care
  • – Consumer Products

  • Financial Services
  • – Piramal Capital & Housing Finance Limited (PCHFL)
  • – India Resurgence Fund (IndiaRF)
Piramal Glass
  • - Piramal Glass (India)
  • - Piramal Glass (USA)
  • - Piramal Glass (Ceylon)
Piramal Realty
  • - Piramal Mahalaxmi
  • - Piramal Aranya
  • - Piramal Revanta
  • - Piramal Vaikunth
  • - Piramal Agastya
Piramal Foundation
  • - Piramal Swasthya
  • - Piramal School of Leadership
  • - Piramal Sarvajal

© 2020 Piramal Enterprises Ltd.

  • Privacy Policy
  • Disclaimer